Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan

Health Policy and Planning

Volumn 30, Issue 8, 2015, Pages 1032-1043

  Dukpa, Wangchuk ^a   Teerawattananon, Yot ^b   Rattanavipapong, Waranya ^b   Srinonprasert, Varalak ^c   Tongsri, Watsamon ^b   Kingkaew, Pritaporn ^b   Yothasamut, Jomkwan ^b   Wangchuk, Dorji ^a   Dorji, Tandin ^a   Wangmo, Kinzang ^a  

^a Ministry of Health   (Bhutan)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bhutan; cost effectiveness analysis; diabetes mellitus; hypertension; non communicable diseases; Package of Essential Non communicable disease interventions (PEN)

Indexed keywords

BHUTAN; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMIC MODEL; ECONOMICS; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; MASS SCREENING; PREVALENCE; PRIMARY HEALTH CARE;

BHUTAN; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; HEALTH RESOURCES; HUMANS; HYPERTENSION; MASS SCREENING; MODELS, ECONOMIC; PREVALENCE; PRIMARY HEALTH CARE;

EID: 84943540083     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czu106     Document Type: Article

References (30)

1. Adler AI, Stevens RJ, Manley SE, et al. (2003). Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International 63: 225-32
2. Blood Pressure Lowering Treatment Trialists' Collaboration. (2000). Effects of ACE inhibitors, calcium antagonists, and other bloodpressure-lowering drugs: results of prospectively designed overviews of randomised trials. The Lancet 356: 1955-64
3. CDC Diabetes Cost-effectiveness Group. (2002). Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287: 2542-51
4. Chobanian AV, Bakris GL, Black HR, et al. (2003). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. The Journal of the American Medical Association 289: 2560-72
5. Coca SG, Ismail-Beigi F, Haq N, et al. (2012). Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Archives of Internal Medicine 172: 761-9
6. Furie KL, Kasner SE, Adams RJ, et al. (2011). Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42: 227-76
7. Giri BR, Sharma KP, Chapagai RN, et al. (2013). Diabetes and hypertension in urban bhutanese men and women. Indian Journal of Community Medicine 38: 138-43
8. Junrungsee S, Kosachunhanun N, Wongthanee A, et al. (2011). History of foot ulcers increases mortality among patients with diabetes in Northern Thailand. Diabetic Medicine 28: 608-11
9. Krittiyawong S, Ngarmukos C, Benjasuratwong Y, et al. (2006). Thailand diabetes registry project: prevalence and risk factors associated with lower extremity amputation in Thai diabetics. Journal of the Medical Association of Thailand 89: S43-8
10. Leelawattana R, Pratipanawatr T, Bunnag P, et al. (2006). Thailand Diabetes Registry Project: Prevalence of Vascular Complications in Long-standing Type 2 Diabete. Journal of the Medical Association of Thailand 89: S54-9
11. Lovibond K, Jowett S, Barton P, et al. (2011). Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. The Lancet 378: 1219-30
12. Lozano R, Naghavi M, Foreman K, et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380: 2095-28
13. Mendis S, Chestnov O. (2013). Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa. Progress in Cardiovascular Diseases 56: 314-21
14. Mulligan J-A, Walker D, Fox-Rushby J. (2006). Economic evaluations of noncommunicable disease interventions in developing countries: a critical review of the evidence base. Cost Effectiveness and Resource Allocation 4: 7
15. Murray CJL, Vos T, Lozano R, et al (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380: 2197-23
16. Non-Communicable Diseases Division. (2013). Package of Essential NCD (PEN) Protocol of BHU's. Bhutan: Ministry of Health
17. Package of Essential NCD (PEN) Protocol of BHU'S. (2013). Bhutan. Non-Communicable Diseases Division, Department of Public Health, Ministry of Health
18. Pratipanawatr T, Rawdaree P, Chetthakul T, et al. (2010). Thailand Diabetic Registry cohort: predicting death in Thai diabetic patients and causes of death. Journal of the Medical Association of Thailand 93: S12-20
19. Qaseem A, Fihn SD, Dallas P, et al. (2012). Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons. Annals of Internal Medicine 157: 735-43
20. Rolka DB, Narayan KMV, Thompson TJ, et al. (2001). Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24: 1899-1903
21. Srimahachota S, Boonyaratavej S, Kanjanavanit R, et al. (2012). Thai Registry in Acute Coronary Syndrome (TRACS)-an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year. J Med Assoc Thai 95: 508-18
22. The International Monetary Fund. (2013). The World Economic Outlook Database. The International Monetary Fund
23. The World Bank. (2011). South Asia Human Development, Health Nutrition, and Population. NCDs Policy Brief-Bhutan. http://siteresources.worldbank.org/SOUTHASIAEXT/Resources/223546-1296680097256/7707437-1296680114157/NCD-BH-Policy-Feb- 2011.pdf (20 September 2014, date last accessed
24. Vijan S, Hofer TP, Hayward RA. (2000). Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. Journal of American Medical Association 283: 889-96
25. Wangchuk D, Virdi NK, Kumar R, et al. (2013). Package of essential non-communicable disease (PEN) interventions in primary health-care settings of Bhutan: a performance assessment study
26. Edejer T, Baltussen R, Hutubessy R, Acharya A, Murray CJL (eds). (2003). World Health Organization. (2003). WHO guide to cost-effectiveness analysis. Geneva: World Health Organization
27. World Health Organization. (2004). Global Burden of Disease 2004 Update: Disability Weights for Diseases and Conditions. Geneva: World Health Organization
28. World Health Organization. (2008). The Global Burden of Disease: 2004 Update. Geneva: World Health Organization
29. World Health Organization. (2010). Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva: World Health Organization
30. World Health Organization. (2013). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: World Health Organization